SMITH JASON DREW (General Counsel) sold 2.8% of their position (1.52K shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $64.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/9/2026ACC: 0001437749-26-029963
Officer· General Counsel
Since Aug 2020
-1.52K
Net shares
Net seller
$64.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.33K acquired · 4.85K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+3.33K
Price / share
—
Trade value
—
% of position
6.5%
9/7/2026
51.33K→54.66K
Ordinary Shares
Direct
Shares
−1.52K
Price / share
$42.54
Trade value
$64.62K
% of position
2.8%
9/8/2026
54.66K→53.14K
Total
Net shares
+1.81K
Net value
-$64.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 9/7/2026 | M · Option Exercise | +3.33K | — | — | 6.5% | 51.33K | 54.66K |
| Ordinary Shares Direct | 9/8/2026 | S · Sale | −1.52K | $42.54 | $64.62K | 2.8% | 54.66K | 53.14K |
| Total | +1.81K | -$64.62K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Ordinary Shares
3.33K shares
Shares
−3.33K
Strike price
Held after
0.00
Exercisable
—
9/7/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares3.33K shares | 9/7/2026 | M · Option Exercise | −3.33K | — | 0.00 |